Ginger Compound Offers New Hope for Inflammatory Bowel Disease Treatment
A groundbreaking study led by the University of Toronto has identified a compound in ginger, furanodienone (FDN), as a promising treatment for inflammatory bowel disease (IBD). Published in Nature Communications, the research highlights how FDN binds to the pregnane X receptor (PXR), a nuclear receptor that regulates inflammation, to reduce colon inflammation without harmful side effects.
The study demonstrated that oral injections of FDN in mice decreased pro-inflammatory cytokines and repaired gut lining damage by boosting tight junction proteins. Unlike current IBD treatments, which often suppress the immune system or harm liver function, FDN offers a safer, cost-effective alternative derived from natural sources.
With IBD rates rising globally due to dietary changes, this discovery u...









